Index by author

November 1, 2022; Volume 63,Issue 11

  1. Laforest, Richard

    1. Phase 1 Evaluation of <sup>11</sup>C-CS1P1 to Assess Safety and Dosimetry in Human Participants
      Phase 1 Evaluation of 11C-CS1P1 to Assess Safety and Dosimetry in Human Participants
      Matthew R. Brier, Mahdjoub Hamdi, Jayashree Rajamanikam, Haiyang Zhao, Syahir Mansor, Lynne A. Jones, Farzaneh Rahmani, Saurabh Jindal, Deborah Koudelis, Joel S. Perlmutter, Dean F. Wong, Michael Nickels, Joseph E. Ippolito, Robert J. Gropler, Thomas H. Schindler, Richard Laforest, Zhude Tu and Tammie L.S. Benzinger
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1775-1782; DOI: https://doi.org/10.2967/jnumed.121.263189

  2. Lambertini, Alessandro

    1. Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PET
      Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
      Andreas K. Buck, Alexander Haug, Niklas Dreher, Alessandro Lambertini, Takahiro Higuchi, Constantin Lapa, Alexander Weich, Martin G. Pomper, Hans-Jürgen Wester, Anja Zehndner, Andreas Schirbel, Samuel Samnick, Marcus Hacker, Verena Pichler, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Sebastian E. Serfling and Rudolf A. Werner
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1687-1692; DOI: https://doi.org/10.2967/jnumed.121.263693

  3. Lampe, Paul D.

    1. CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
      CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
      Andrew G. Kunihiro, Samantha M. Sarrett, Kristin J. Lastwika, Joell L. Solan, Tatyana Pisarenko, Outi Keinänen, Cindy Rodriguez, Lydia R. Taverne, Annette L. Fitzpatrick, Christopher I. Li, A. McGarry Houghton, Brian M. Zeglis and Paul D. Lampe
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1701-1707; DOI: https://doi.org/10.2967/jnumed.121.263511

  4. Langen, Karl-Josef

    1. Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schäfer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1677-1682; DOI: https://doi.org/10.2967/jnumed.122.263790

  5. Lapa, Constantin

    1. Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PET
      Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
      Andreas K. Buck, Alexander Haug, Niklas Dreher, Alessandro Lambertini, Takahiro Higuchi, Constantin Lapa, Alexander Weich, Martin G. Pomper, Hans-Jürgen Wester, Anja Zehndner, Andreas Schirbel, Samuel Samnick, Marcus Hacker, Verena Pichler, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Sebastian E. Serfling and Rudolf A. Werner
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1687-1692; DOI: https://doi.org/10.2967/jnumed.121.263693

  6. Lastwika, Kristin J.

    1. CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
      CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
      Andrew G. Kunihiro, Samantha M. Sarrett, Kristin J. Lastwika, Joell L. Solan, Tatyana Pisarenko, Outi Keinänen, Cindy Rodriguez, Lydia R. Taverne, Annette L. Fitzpatrick, Christopher I. Li, A. McGarry Houghton, Brian M. Zeglis and Paul D. Lampe
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1701-1707; DOI: https://doi.org/10.2967/jnumed.121.263511

  7. Lee, Jeyeon

    1. The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability
      Open Access
      The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability
      Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G. Schwarz, David T. Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen and Val J. Lowe
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1748-1753; DOI: https://doi.org/10.2967/jnumed.121.263136

  8. Lee, Yu-Jin

    1. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Open Access
      Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Quan Zhou, Nynke S. van den Berg, Wenying Kang, Jacqueline Pei, Naoki Nishio, Stan van Keulen, Myrthe A. Engelen, Yu-Jin Lee, Marisa Hom, Johana C.M. Vega Leonel, Zachary Hart, Hannes Vogel, Romain Cayrol, Brock A. Martin, Mark Roesner, Glenn Shields, Natalie Lui, Melanie Hayden Gephart, Roan C. Raymundo, Grace Yi, Monica Granucci, Gerald A. Grant, Gordon Li and Eben L. Rosenthal
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1693-1700; DOI: https://doi.org/10.2967/jnumed.121.263674

  9. Levin, Johannes

    1. Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices
      Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices
      Ping Wu, Yu Zhao, Jianjun Wu, Matthias Brendel, Jiaying Lu, Jingjie Ge, Alexander Bernhardt, Ling Li, Ian Alberts, Sabrina Katzdobler, Igor Yakushev, Jimin Hong, Qian Xu, Yimin Sun, Fengtao Liu, Johannes Levin, Günter U. Höglinger, Claudio Bassetti, Yihui Guan, Wolfgang H. Oertel, Wolfgang Weber, Axel Rominger, Jian Wang, Chuantao Zuo and Kuangyu Shi
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1741-1747; DOI: https://doi.org/10.2967/jnumed.121.263029
    2. <sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
      18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
      Konstantin Messerschmidt, Henryk Barthel, Matthias Brendel, Cordula Scherlach, Karl-Titus Hoffmann, Boris-Stephan Rauchmann, Michael Rullmann, Kenneth Marek, Victor L. Villemagne, Jost-Julian Rumpf, Dorothee Saur, Matthias L. Schroeter, Andreas Schildan, Marianne Patt, Leonie Beyer, Mengmeng Song, Carla Palleis, Sabrina Katzdobler, Urban M. Fietzek, Gesine Respondek, Maximilian Scheifele, Alexander Nitschmann, Christian Zach, Olivier Barret, Jennifer Madonia, David Russell, Andrew W. Stephens, Norman Koglin, Sigrun Roeber, Jochen Herms, Kai Bötzel, Peter Bartenstein, Johannes Levin, John P. Seibyl, Günter Höglinger, Joseph Classen, Osama Sabri and for the German Imaging Initiative for Tauopathies (GII4T)
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1754-1760; DOI: https://doi.org/10.2967/jnumed.121.262854

  10. Li, Christopher I.

    1. CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
      CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
      Andrew G. Kunihiro, Samantha M. Sarrett, Kristin J. Lastwika, Joell L. Solan, Tatyana Pisarenko, Outi Keinänen, Cindy Rodriguez, Lydia R. Taverne, Annette L. Fitzpatrick, Christopher I. Li, A. McGarry Houghton, Brian M. Zeglis and Paul D. Lampe
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1701-1707; DOI: https://doi.org/10.2967/jnumed.121.263511
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue